GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 96 filers reported holding GENERATION BIO CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $116,243 | -27.6% | 30,671 | +5.1% | 0.00% | – |
| Q2 2023 | $160,562 | +94907.1% | 29,193 | -25.8% | 0.00% | – |
| Q1 2023 | $169 | +65.7% | 39,318 | +51.7% | 0.00% | – |
| Q4 2022 | $102 | -99.8% | 25,918 | +150.5% | 0.00% | – |
| Q3 2022 | $55,000 | -88.1% | 10,347 | -85.3% | 0.00% | – |
| Q2 2022 | $463,000 | -87.9% | 70,560 | -86.9% | 0.00% | -100.0% |
| Q4 2021 | $3,812,000 | +278.6% | 538,391 | +1338.0% | 0.00% | +100.0% |
| Q2 2021 | $1,007,000 | +3.7% | 37,440 | +9.3% | 0.00% | 0.0% |
| Q4 2020 | $971,000 | -82.4% | 34,258 | -86.9% | 0.00% | -87.5% |
| Q2 2020 | $5,511,000 | – | 262,408 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $54,309,000 | 9.08% |
| Artal Group S.A. | 2,814,191 | $18,461,000 | 0.99% |
| HighVista Strategies LLC | 248,994 | $1,633,000 | 0.99% |
| Yiheng Capital Management, L.P. | 2,597,631 | $17,040,000 | 0.97% |
| PFM Health Sciences, LP | 2,773,313 | $18,193,000 | 0.69% |
| BVF INC/IL | 1,556,032 | $10,273,000 | 0.50% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,348,000 | 0.39% |
| Bellevue Group AG | 3,627,280 | $23,795,000 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,897,300 | $19,006,000 | 0.10% |
| Corton Capital Inc. | 15,493 | $102,000 | 0.10% |